In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Pharma Ready to Pare Portfolios, Project Financing Funds Make Their Pitches

Executive Summary

Drug firms need to find good homes for hundreds of early-stage experimental compounds that ideally they could claw back once new developers demonstrate proof-of-concept. New project financing funds are clamoring for those assets, but first they must convince LPs to invest in unproven financing models, deal with pharma's accounting demands, and negotiate deals with asset-holders that will provide a decent return.
Advertisement

Related Content

A Look Back At 2010: In Search Of New Biopharma Models
Biotech Backers Are Learning to Live with Exit-by-Earn-out
Finding Inspiration: Ipsen Builds Fourth Specialist Franchise With Hemophilia Deal
Flexion Exploits Big Pharma as Discovery Supplier
Flexion Exploits Big Pharma as Discovery Supplier
GSK And Pfizer Join Forces In New HIV-Focused Venture
Symphony's Project Financing Model Adapts
Symphony's Project Financing Model Adapts
Symphony & Guilford Try Out Project Financing
Guilford To Receive $40 Mil. To Fund Parkinson's/ED Drug Development Via Investment Deal

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel